Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years
Clinical trial NCT05760261 · COMPLETED
Trial details
- NCT number
- NCT05760261
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2024-08-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.